bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
All Web sites
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2014: A J J M A M F J
2013: D N O S A

 
  Other news for:
Child Psychology
Mental Retardation
 Resources from HONselect
Too Many Foster Kids With ADHD Treated With Antipsychotic Drugs: Study
Researchers looked at unapproved 'atypical' use of these meds in one state

By Robert Preidt

THURSDAY, April 10, 2014 (HealthDay News) -- Antipsychotic drugs are increasingly being prescribed to treat attention-deficit/hyperactivity disorder (ADHD) in children and teens in foster care, according to a new study.

The use of these drugs to treat ADHD has not been approved by the U.S. Food and Drug Administration, and is known as an "atypical" use, the researchers explained.

But their study found that antipsychotics were used to treat nearly one-third of foster care youth aged 2 to 17 who had been diagnosed with ADHD. The most common types of antipsychotics used were risperidone, aripiprazole and quetiapine.

The study looked at administrative data on more than 260,000 youths aged 2 to 17, enrolled in one state's Medicaid program in 2006, to determine the average number of days of atypical antipsychotic use in kids. Researchers also looked specifically at a subgroup of kids with ADHD who were not diagnosed with any other mental health conditions.

The findings by researcher Julie Magno Zito, at the University of Maryland at Baltimore, and colleagues were published online recently in the Journal of Child and Adolescent Psychopharmacology.

"This study adds critical hard data to our understanding of a persistent and unacceptable trend in pediatric psychiatry," Dr. Harold Koplewicz, journal editor-in-chief and president of the Child Mind Institute in New York City, said in a journal news release.

"Our poorest, most vulnerable children, lacking access to evidence-based care, are receiving potentially harmful treatment with little oversight. The highlight of [the] paper for any reader should be the simple but necessary recommendations for antipsychotic prescribing and monitoring in these populations," he added.

More information

The U.S. Centers for Disease Control and Prevention has more about ADHD treatments.

SOURCE: Journal of Child and Adolescent Psychopharmacology, news release, April 7, 2014

Copyright © 2014 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=686601

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Specialty Chemicals and Products
Research Personnel
Psychopharmacology
Therapeutics
Aged
Mental Health
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact